Unpleasant truths about salt restriction

Seminars in Dialysis

Volumn 23, Issue 1, 2010, Pages 1-3

  Ok, Ercan ^a   Mees, Evert J Dorhout ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VOLUME; EDITORIAL; HEART DISEASE; HUMAN; HYPERTENSION; RENAL REPLACEMENT THERAPY; SODIUM RESTRICTION;

BLOOD VOLUME; DIET, SODIUM-RESTRICTED; HEART DISEASES; HUMANS; HYPERTENSION; RENAL DIALYSIS;

EID: 77950259374     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2009.00670.x     Document Type: Editorial

References (21)

1. Guyton AC. Kidneys and fluids in pressure regulation. Small volume but large pressure changes. Hypertension 1992, 19(Suppl. 1):I2-I8.
2. Borst JJG, Borst-de Geus A. Hypertension explained by Starlings theory of circulatory homeostasis. Lancet 1963, 1:677-682.
3. Bots CP, Brand HS, Veerman EC, Valentijn-Benz M, Van Amerongen BM, Valentijn RM, Vos PF, Bijlsma JA, Bezemer PD, Ter Wee PM, Amerongen AV. Interdialytic weight gain in patients on hemodialysis is associated with dry mouth and thirst. Kidney Int 2004, 66:1662-1668.
4. Ozkahya M, Ok E, Toz H, Asci G, Duman S, Basci A, Kose T, Dorhout Mees EJ. Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant 2006, 21:3506-3513.
5. Parfrey PS, Harnett JD, Griffiths SM, Gault MH, Barré PE. Congestive heart failure in dialysis patients. Arch Intern Med 1988, 148:1519-1525.
6. Echna LW. Circulatory congestion and heart failure. Circulation 1960, 22:864-865.
7. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995, 47:884-890.
8. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int 1998, 54:1720-1725.
9. Ozkahya M, Ok E, Cirit M, Aydin S, Akçiçek F, Başçi A, Dorhout Mees EJ. Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant 1998, 13:1489-1493.
10. Kayikcioglu M, Tumuklu M, Ozkahya M, Ozdogan O, Asci G, Duman S, Toz H, Can LH, Basci A, Ok E. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant 2009, 24:956-962.
11. Szidon JP. Pathophysiology of the congested lung. Cardiol Clin 1989, 7:39-48.
12. Drüeke T, Le Pailleur C, Meilhac B, Koutoudis C, Zingraff J, Di Matteo J, Crosnier J. Congestive cardiomyopathy in uraemic patients on long term haemodialysis. Br Med J 1977, 1:350-353.
13. Cirit M, Ozkahya M, Cinar CS, Ok E, Aydin S, Akçiçek F, Dorhout Mees EJ. Disappearance of mitral and tricuspid regurgitation in haemodialysis patients after ultrafiltration. Nephrol Dial Transplant 1998, 13:389-392.
14. Töz H, Ozkahya M, Ozerkan F, Aşçi G, Ok E. Improvement in " uremic" cardiomyopathy by persistent ultrafiltration. Hemodial Int 2007, 11:46-50.
15. Parfrey PS, Harnett JD, Barre PE. The natural history of myocardial disease in dialysis patients. J Am Soc Nephrol 1991, 2:2-12.
16. Töz H, Ozerkan F, Unsal A, Soydas C, Dorhout Mees EJ. Dilated uremic cardiomyopathy in a dialysis patient cured by persistent ultrafiltration. Am J Kidney Dis 1998, 32:664-668.
17. Hanneman RL. Intersalt: hypertension rise with age revisited. BMJ 1996, 312:1283-1284.
18. Godlee F. The food industry fights for salt. BMJ 1996, 312:1239-1240.
19. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981, 305:1176-1181.
20. Shaldon S, Koch KM. Are standards and checklists needed in uremia therapy? Kidney Int Suppl 1985, 28(Suppl. 17):S124-S126.
21. Titze J. Water free sodium accumulation. Semin Dial 2009, 22:253-255.